GVAG
CNSY

Great Valley Advisor Group’s Cerenome, Inc. Common Stock CNSY Stock Holding History

Great Valley Advisor Group’s Portfolio CNSY Stock Details CNSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-90
Closed -$9.74K – 734
2023
Q1 		$9.74K Hold
90
– – ﹤0.01% 693
2022
Q4 		$10.7K Hold
90
– – ﹤0.01% 685
2022
Q3 		$15K Hold
90
– – ﹤0.01% 663
2022
Q2 		$18K Buy
+90
New +$22.5K ﹤0.01% 662

Other funds holding CNSY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Great Valley Advisor Group's CNSY Position: Q2 2023 in Review

Great Valley Advisor Group sold out of Cerenome, Inc. Common Stock (CNSY) in Q2 2023, closing a stake of 90 shares — an estimated $9.74K sold.

Great Valley Advisor Group first reported a position in CNSY in Q2 2022 and held it in 4 quarters. The position peaked at $18K in Q2 2022. 6 funds tracked by Wall St. Rank hold CNSY as of Q2 2023.

  • Great Valley Advisor Group reported no remaining Cerenome, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Great Valley Advisor Group sold 90 Cerenome, Inc. Common Stock shares in Q2 2023, an estimated $9.74K.
  • Great Valley Advisor Group first reported a position in Cerenome, Inc. Common Stock in Q2 2022 and held it in 4 quarters.
  • Great Valley Advisor Group's Cerenome, Inc. Common Stock position peaked at $18K in Q2 2022.
  • 6 funds tracked by Wall St. Rank held Cerenome, Inc. Common Stock as of Q2 2023.

Based on Great Valley Advisor Group's 13F filing for Q2 2023, filed 10 Aug 2023.